RESUMO
ABSTRACT: Nausea and vomiting may occur in cancer survivors during or independent of treatment. A complete assessment is necessary to determine the etiology and to plan specific and successful interventions. NPs have a key role in managing cancer survivors' symptoms and determining the best supportive care.
Assuntos
Sobreviventes de Câncer , Neoplasias , Humanos , Neoplasias/complicações , Náusea/etiologia , Vômito/complicações , Qualidade de VidaRESUMO
BACKGROUND: The increasing number and complexity of oral agents for cancer (OACs) have created a paradigm shift in the process and outcomes in oncology care. With 25%-30% of new oncology medications in development being oral agents, and a steady increase in approvals in the past 5-10 years, the issues are relevant in clinical practice. OBJECTIVES: The purpose of this article is to provide an overview of the challenges related to OACs, including adherence, and to describe the consequences of adherence and resources for oncology nurses. METHODS: The literature was searched to determine challenges related to OACs and their impact on adherence, and an overview of the issues was compiled. FINDINGS: Oncology nurses are key stakeholders in recognizing the challenges and issues associated with the change in treatment regarding OACs. Oncology nurses are an integral part of managing the oral agent process, from access to adherence. Oncology nurses need to understand the issues surrounding OACs so that adherence practices can be improved.
Assuntos
Antineoplásicos/administração & dosagem , Adesão à Medicação/estatística & dados numéricos , Neoplasias/tratamento farmacológico , Neoplasias/enfermagem , Enfermagem Oncológica/métodos , Administração Oral , Feminino , Humanos , Masculino , Neoplasias/diagnóstico , Papel do Profissional de Enfermagem , Planejamento de Assistência ao Paciente/organização & administração , Segurança do Paciente , Medição de Risco , Resultado do TratamentoRESUMO
Chemotherapy-induced nausea and vomiting (CINV) continues to have a considerable effect on the physical and psychological well-being of patients with cancer, despite significant advances in antiemetic drugs since the 1990s. This article reviews and summarizes past and current empirical evidence related to interventions for CINV. A resource that summarizes evidence-based interventions for CINV is critical for effective management of this distressing symptom. Pharmacologic and nonpharmacologic interventions are appraised. Finally, gaps in the literature and opportunities for research, education, and practice changes are discussed.
